董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| James A. Deal | 男 | Director | 70 | 未披露 | 未持股 | 2022-01-06 |
| Jack Krouskup | 男 | Director | 71 | 未披露 | 未持股 | 2022-01-06 |
| Joseph R. Swedish | 男 | Chairman | 70 | 未披露 | 未持股 | 2022-01-06 |
| James T. Olsen | 男 | Chief Executive Officer and Director | 49 | 未披露 | 未持股 | 2022-01-06 |
| Ken Goulet | 男 | Director | 61 | 未披露 | 未持股 | 2022-01-06 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| James T. Olsen | 男 | Chief Executive Officer and Director | 49 | 未披露 | 未持股 | 2022-01-06 |
| Benson Jose | 男 | Chief Financial Officer | 41 | 未披露 | 未持股 | 2022-01-06 |
董事简历
中英对照 | 中文 | 英文- James A. Deal
-
James A. Deal，他曾担任AmSurg公司的董事（从1992年到2016年11月）。他曾担任Compassus公司（临终关怀的供应商）的总裁兼首席执行官（2006年7月以来）。2006年期间，他曾担任INSPIRIS, Inspired Care for the Frail Elderly的董事长。2011年11月至2005年12月，他曾担任INSPIRIS的董事长兼首席执行官。从1998年9月到2001年6月，他曾担任Center for Diagnostic Imaging, Inc.（一个全国的门诊诊断影像中心）的总裁、首席执行官和董事。他曾担任Healthways, Inc（疾病管理公司）的执行副总裁（从1991年1月到1998年8月），以及Diabetes Treatment Centers of America, Inc.（现称为American Healthways Services, Inc.，Healthways的子公司）的总裁（1985年至1998年8月）。
James A. Deal has served as a director since the initial public offering. He is the Founder, Chief Executive Officer and Director of Compassus, a leading national hospice, palliative care and home health post-acute provider. Mr. Deal partnered with ThomaCressey Bravo to found Compassus in 2006. Under his leadership, Compassus has grown into one of the nation's largest hospice providers with locations in more than 25 states. As the CEO of multiple healthcare companies during his career, Mr. Deal has overseen numerous projects aimed at expanding access and providing better care to patients. He led the creation of a national network of diabetes treatment centers, developed at-risk disease/care management contracts in the U.S and grew a regional medical imaging business into a multi-regional provider.Mr. Deal has extensive history with both Envision Healthcare and AMSURG pre-dating their combination in 2016. He spent more than 25 years with Envision, a leading provider of physician-led services and post-acute care, and ambulatory surgery services. AMSURG, now part of Envision, is a market leader in strategic and operational management of surgery centers, owning and operating more than 260 surgery centers and one surgical hospital in 35 states and the District of Columbia. Mr. Deal served on the Board of Directors for Envision from 1999 until October 2018. At AMSURG, Mr. Deal served on the Operating Board prior to the company's IPO spin out from Healthways. Previously, Mr. Deal served on the Board of MedCath, a leading operator of cardiac specialty hospitals. Mr. Deal received a B.S. in Economics from Western Illinois University and a Master's of Public Administration in Health Services Administration from the University of Arizona. - James A. Deal，他曾担任AmSurg公司的董事（从1992年到2016年11月）。他曾担任Compassus公司（临终关怀的供应商）的总裁兼首席执行官（2006年7月以来）。2006年期间，他曾担任INSPIRIS, Inspired Care for the Frail Elderly的董事长。2011年11月至2005年12月，他曾担任INSPIRIS的董事长兼首席执行官。从1998年9月到2001年6月，他曾担任Center for Diagnostic Imaging, Inc.（一个全国的门诊诊断影像中心）的总裁、首席执行官和董事。他曾担任Healthways, Inc（疾病管理公司）的执行副总裁（从1991年1月到1998年8月），以及Diabetes Treatment Centers of America, Inc.（现称为American Healthways Services, Inc.，Healthways的子公司）的总裁（1985年至1998年8月）。
- James A. Deal has served as a director since the initial public offering. He is the Founder, Chief Executive Officer and Director of Compassus, a leading national hospice, palliative care and home health post-acute provider. Mr. Deal partnered with ThomaCressey Bravo to found Compassus in 2006. Under his leadership, Compassus has grown into one of the nation's largest hospice providers with locations in more than 25 states. As the CEO of multiple healthcare companies during his career, Mr. Deal has overseen numerous projects aimed at expanding access and providing better care to patients. He led the creation of a national network of diabetes treatment centers, developed at-risk disease/care management contracts in the U.S and grew a regional medical imaging business into a multi-regional provider.Mr. Deal has extensive history with both Envision Healthcare and AMSURG pre-dating their combination in 2016. He spent more than 25 years with Envision, a leading provider of physician-led services and post-acute care, and ambulatory surgery services. AMSURG, now part of Envision, is a market leader in strategic and operational management of surgery centers, owning and operating more than 260 surgery centers and one surgical hospital in 35 states and the District of Columbia. Mr. Deal served on the Board of Directors for Envision from 1999 until October 2018. At AMSURG, Mr. Deal served on the Operating Board prior to the company's IPO spin out from Healthways. Previously, Mr. Deal served on the Board of MedCath, a leading operator of cardiac specialty hospitals. Mr. Deal received a B.S. in Economics from Western Illinois University and a Master's of Public Administration in Health Services Administration from the University of Arizona.
- Jack Krouskup
-
Jack Krouskup是审计和风险委员会以及治理和提名委员会的成员。Krouskup先生自2012年以来一直在我们的董事会任职。他是一名不活跃的注册会计师，拥有超过35年的经验，服务于各种行业的客户。在Deloitte，他担任该公司北加州金融服务实践的合伙人负责人，也任职于Deloitte的金融服务咨询委员会。Krouskup先生在众多全球和高度复杂的组织中代表德勤（Deloitte）拥有多年的董事会经验。因此，他拥有广泛的公司治理背景，以及对董事会和审计委员会最佳实践的深刻熟悉。Mr.Krouskup于2011年从Deloitte退休。他目前任职于加州大学圣巴巴拉分校（the University of California，Santa Barbara）的董事会。
Jack Krouskup has served as a director since the initial public offering. Mr. Krouskup has more than 35 years' experience serving customers in a variety of industries. He was employed by Deloitte from June 1972 through May 2011 where he was the former Partner-in-charge of Deloitte's Northern California financial services practice and served on Deloitte's financial services advisory committee. Mr. Krouskup has years of boardroom experience representing Deloitte with numerous global and highly complex organizations, including Kaiser Permanente, McKesson, the University of California Medical Centers, Pacific Gas & Electric and Clorox Company. He has an extensive corporate governance background and deep familiarity with board and audit committee best practices. He has served numerous companies across the healthcare industry in both services and life sciences, including several IPO and merger transactions. Mr. Krouskup has broad experience in SEC matters and other accounting and reporting requirements including initial public offerings, debt and equity registrations, responding to SEC comment letters and foreign statutory audit filings. He currently serves as Chairman of the Board of Directors of Verity Health System, a position he has held since December 2015. He has been a member of the Boards of Directors of Luther Burbanks Savings Corporation since July 2012 and Teton Literacy Center since July 2018. In addition, he is an advisor at Magnolia Medical Technologies. Mr. Krouskup received a B.A. in Economics at University of California, Santa Barbara, and a bachelor's degree in Business at San Jose State University. He is a past president of the University of California, Santa Barbara, Alumni Association Board of Directors and since July 2012 has served on the university's Board of Trustees. - Jack Krouskup是审计和风险委员会以及治理和提名委员会的成员。Krouskup先生自2012年以来一直在我们的董事会任职。他是一名不活跃的注册会计师，拥有超过35年的经验，服务于各种行业的客户。在Deloitte，他担任该公司北加州金融服务实践的合伙人负责人，也任职于Deloitte的金融服务咨询委员会。Krouskup先生在众多全球和高度复杂的组织中代表德勤（Deloitte）拥有多年的董事会经验。因此，他拥有广泛的公司治理背景，以及对董事会和审计委员会最佳实践的深刻熟悉。Mr.Krouskup于2011年从Deloitte退休。他目前任职于加州大学圣巴巴拉分校（the University of California，Santa Barbara）的董事会。
- Jack Krouskup has served as a director since the initial public offering. Mr. Krouskup has more than 35 years' experience serving customers in a variety of industries. He was employed by Deloitte from June 1972 through May 2011 where he was the former Partner-in-charge of Deloitte's Northern California financial services practice and served on Deloitte's financial services advisory committee. Mr. Krouskup has years of boardroom experience representing Deloitte with numerous global and highly complex organizations, including Kaiser Permanente, McKesson, the University of California Medical Centers, Pacific Gas & Electric and Clorox Company. He has an extensive corporate governance background and deep familiarity with board and audit committee best practices. He has served numerous companies across the healthcare industry in both services and life sciences, including several IPO and merger transactions. Mr. Krouskup has broad experience in SEC matters and other accounting and reporting requirements including initial public offerings, debt and equity registrations, responding to SEC comment letters and foreign statutory audit filings. He currently serves as Chairman of the Board of Directors of Verity Health System, a position he has held since December 2015. He has been a member of the Boards of Directors of Luther Burbanks Savings Corporation since July 2012 and Teton Literacy Center since July 2018. In addition, he is an advisor at Magnolia Medical Technologies. Mr. Krouskup received a B.A. in Economics at University of California, Santa Barbara, and a bachelor's degree in Business at San Jose State University. He is a past president of the University of California, Santa Barbara, Alumni Association Board of Directors and since July 2012 has served on the university's Board of Trustees.
- Joseph R. Swedish
-
Joseph R. Swedish于2013年加入Anthem担任首席执行官，并于2015年被任命为Anthem董事会主席。他一直担任董事长，首席执行官和总裁，直到2017年底退休并成为执行董事长为止。 于2018年5月退休。
Joseph R. Swedish,is the former Chairman, President and Chief Executive Officer of Anthem, Inc., a health benefits provider, now known as Elevance Health, Inc. Mr. Swedish served as President and Chief Executive Officer of Anthem from 2013 to November 2017, became Chairman in 2015 and became Executive Chairman in November 2017. From his retirement in May 2018 to May 2020, Mr. Swedish served as a Senior Advisor to Anthem. Prior to joining Anthem, Mr. Swedish was President and Chief Executive Officer of Trinity Health, an eighteen-state integrated health care delivery system, from 2004 to 2013. From 1993 to 2013, Mr. Swedish held CEO and senior executive leadership positions with Centura Health, Hospital Corporation of America and other healthcare enterprises. Mr. Swedish also is the co-founder and partner emeritus of Concord Health Partners, LLC, a private equity firm focused on strategic investing in healthcare portfolio companies. - Joseph R. Swedish于2013年加入Anthem担任首席执行官，并于2015年被任命为Anthem董事会主席。他一直担任董事长，首席执行官和总裁，直到2017年底退休并成为执行董事长为止。 于2018年5月退休。
- Joseph R. Swedish,is the former Chairman, President and Chief Executive Officer of Anthem, Inc., a health benefits provider, now known as Elevance Health, Inc. Mr. Swedish served as President and Chief Executive Officer of Anthem from 2013 to November 2017, became Chairman in 2015 and became Executive Chairman in November 2017. From his retirement in May 2018 to May 2020, Mr. Swedish served as a Senior Advisor to Anthem. Prior to joining Anthem, Mr. Swedish was President and Chief Executive Officer of Trinity Health, an eighteen-state integrated health care delivery system, from 2004 to 2013. From 1993 to 2013, Mr. Swedish held CEO and senior executive leadership positions with Centura Health, Hospital Corporation of America and other healthcare enterprises. Mr. Swedish also is the co-founder and partner emeritus of Concord Health Partners, LLC, a private equity firm focused on strategic investing in healthcare portfolio companies.
- James T. Olsen
-
JamesT.Olsen自成立以来一直担任我们的首席执行官和董事。Olsen先生是Concord的创始人兼管理合伙人，也是Concord&8217；s投资委员会的成员。Olsen先生在梦百合投资银行和投资咨询服务方面有超过24年的经验。在2017年成立Concord之前，Olsen先生曾于2013年至2016年担任多元化金融服务公司Jefferies的董事总经理兼非营利梦百合投资银行业务主管。任职Jefferies公司之前，奥尔森曾担任美银美林（Bank of America Merrill Lynch）的董事总经理兼非营利性梦百合并购主管。他的职业生涯始于1996年任职Merrill Lynch公司，在那里他曾任职17年。他目前任职于VitalTech Holdings公司（梦百合信息技术领域的协和投资组合公司，专注于远程患者监测）和Proton Therapy Partners公司（专业服务供应商，与医院公司组建合资企业，提供先进的质子治疗放射肿瘤服务）的董事会。Olsen先生在马里兰洛约拉大学（Loyola University Maryland）获得物理学学士学位，并在马里兰大学医学院（University of Maryland Graduate Program）获得生理学硕士学位。
James T. Olsen has served as our Chief Executive Officer and a Director since inception. Mr. Olsen is the Founder & Managing Partner of Concord and a member of Concord's Investment Committee. Mr. Olsen has over 24 years of experience in healthcare investment banking and investment advisory services. Prior to founding Concord in 2017 Mr. Olsen was Managing Director & Head of Not-for-Profit Healthcare Investment Banking at Jefferies, a diversified financial services company from 2013 to 2016. Prior to Jefferies, Mr. Olsen served as Managing Director & Head of Not-for-Profit Healthcare Mergers & Acquisitions at Bank of America Merrill Lynch. Mr. Olsen began his career in 1996 at Merrill Lynch where he remained for 17 years. He currently serves on the Board of Directors for VitalTech Holdings, a Concord portfolio company in the healthcare information technology sector that focuses on remote patient monitoring, and Proton Therapy Partners, a specialty service provider that forms joint ventures with hospital companies to deliver advanced proton therapy radiation oncology services. Mr. Olsen received a B.S. in Physics from Loyola University Maryland and a M.S. in Physiology from the University of Maryland Graduate Program at the School of Medicine. - JamesT.Olsen自成立以来一直担任我们的首席执行官和董事。Olsen先生是Concord的创始人兼管理合伙人，也是Concord&8217；s投资委员会的成员。Olsen先生在梦百合投资银行和投资咨询服务方面有超过24年的经验。在2017年成立Concord之前，Olsen先生曾于2013年至2016年担任多元化金融服务公司Jefferies的董事总经理兼非营利梦百合投资银行业务主管。任职Jefferies公司之前，奥尔森曾担任美银美林（Bank of America Merrill Lynch）的董事总经理兼非营利性梦百合并购主管。他的职业生涯始于1996年任职Merrill Lynch公司，在那里他曾任职17年。他目前任职于VitalTech Holdings公司（梦百合信息技术领域的协和投资组合公司，专注于远程患者监测）和Proton Therapy Partners公司（专业服务供应商，与医院公司组建合资企业，提供先进的质子治疗放射肿瘤服务）的董事会。Olsen先生在马里兰洛约拉大学（Loyola University Maryland）获得物理学学士学位，并在马里兰大学医学院（University of Maryland Graduate Program）获得生理学硕士学位。
- James T. Olsen has served as our Chief Executive Officer and a Director since inception. Mr. Olsen is the Founder & Managing Partner of Concord and a member of Concord's Investment Committee. Mr. Olsen has over 24 years of experience in healthcare investment banking and investment advisory services. Prior to founding Concord in 2017 Mr. Olsen was Managing Director & Head of Not-for-Profit Healthcare Investment Banking at Jefferies, a diversified financial services company from 2013 to 2016. Prior to Jefferies, Mr. Olsen served as Managing Director & Head of Not-for-Profit Healthcare Mergers & Acquisitions at Bank of America Merrill Lynch. Mr. Olsen began his career in 1996 at Merrill Lynch where he remained for 17 years. He currently serves on the Board of Directors for VitalTech Holdings, a Concord portfolio company in the healthcare information technology sector that focuses on remote patient monitoring, and Proton Therapy Partners, a specialty service provider that forms joint ventures with hospital companies to deliver advanced proton therapy radiation oncology services. Mr. Olsen received a B.S. in Physics from Loyola University Maryland and a M.S. in Physiology from the University of Maryland Graduate Program at the School of Medicine.
- Ken Goulet
-
Ken Goulet自首次公开募股以来一直担任董事。Goulet先生是一位高级医疗保健执行官，在成长和领导大型医疗计划组织方面拥有超过30年的经验。从2004年4月到2015年9月，Goulet先生在Anthem，Inc.工作，最近担任执行Vice President，并担任Anthem&8217；的商业和专业业务部门（美国最大的商业健康保险业务部门之一）的总裁。担任该职位时，他负责Anthem&8217；的个人和交换业务、本地蓝色业务、国民账户和专业产品。他的职责包括战略、营销、产品管理、医疗管理、供应商参与和承包及服务运营。在被任命为执行Vice President之前，Goulet先生曾在Anthem担任过各种行政领导职务，包括雇主、医疗补助、个人和专业业务部门的总裁兼首席执行官；前商业业务部门的总裁兼首席执行官以及国民账户部门的总裁兼首席执行官。在加入Anthem之前，Goulet先生在信诺保险集团公司工作了23年，担任过多个管理、销售和运营职位。Goulet目前在梦百合行业的几家私营公司担任董事，这些公司包括Behavior Health Group、Enperx、IPG、OODA Health、Quartet Health和Sharecare。他也任职Brave Health公司、CareCentrix公司和Nationshearing公司的咨询委员会。在2015年12月至2018年8月被Veritas Capital收购之前，Goulet先生曾在Cotiviti NYSE:COTV董事会任职。从2016年4月至2017年3月，Goulet先生曾在Surgical Care Affiliates（纳斯达克股票代码:SCAI）的董事会任职，然后被UnitedHealth’；s Optum收购。Goulet先生在康涅狄格州哈特福德的三一学院（Trinity College）获得经济学学士学位。
Ken Goulet has served as a director since the initial public offering. Mr. Goulet is a senior-level health care executive with over 30 years' experience in growing and leading large health plan organizations. From April 2004 until September 2015 Mr. Goulet worked at Anthem, Inc., most recently serving as the executive vice president, and president of the Anthem's Commercial and Specialty Business division - one of the largest commercial health insurance business divisions in the United States. In that role, he was responsible for Anthem's Individual and Exchange business, Local Blue business, National Accounts and Specialty Products. His responsibilities included strategy, marketing, product management, medical management, provider engagement and contracting and service operations. Prior to his appointment as executive vice president, Mr. Goulet served in various executive leadership roles at Anthem, including President and CEO of the Employer, Medicaid, Individual and Specialty Business Unit; President and CEO of the former Commercial Business Unit and President and CEO of National Accounts. Before joining Anthem, Mr. Goulet spent 23 years at Cigna Corporation where he held a number of management, sales and operations positions. Mr. Goulet currently serves on the board of directors of several privately held companies within the healthcare industry including Behavioral Health Group, EmpiRx, IPG, OODA Health, Quartet Health and Sharecare. He also sits on the advisory boards of Brave Health, Carecentrix and NationsHearing. From December 2015 until August 2018 Mr. Goulet served on the Board of Cotiviti NYSE: COTV, prior to its acquisition by Veritas Capital. From April 2016 until March 2017 Mr. Goulet served on the board of Surgical Care Affiliates (Nasdaq: SCAI), prior to its acquisition by UnitedHealth's Optum. Mr. Goulet received a bachelor's degree in Economics at Trinity College in Hartford, Connecticut. - Ken Goulet自首次公开募股以来一直担任董事。Goulet先生是一位高级医疗保健执行官，在成长和领导大型医疗计划组织方面拥有超过30年的经验。从2004年4月到2015年9月，Goulet先生在Anthem，Inc.工作，最近担任执行Vice President，并担任Anthem&8217；的商业和专业业务部门（美国最大的商业健康保险业务部门之一）的总裁。担任该职位时，他负责Anthem&8217；的个人和交换业务、本地蓝色业务、国民账户和专业产品。他的职责包括战略、营销、产品管理、医疗管理、供应商参与和承包及服务运营。在被任命为执行Vice President之前，Goulet先生曾在Anthem担任过各种行政领导职务，包括雇主、医疗补助、个人和专业业务部门的总裁兼首席执行官；前商业业务部门的总裁兼首席执行官以及国民账户部门的总裁兼首席执行官。在加入Anthem之前，Goulet先生在信诺保险集团公司工作了23年，担任过多个管理、销售和运营职位。Goulet目前在梦百合行业的几家私营公司担任董事，这些公司包括Behavior Health Group、Enperx、IPG、OODA Health、Quartet Health和Sharecare。他也任职Brave Health公司、CareCentrix公司和Nationshearing公司的咨询委员会。在2015年12月至2018年8月被Veritas Capital收购之前，Goulet先生曾在Cotiviti NYSE:COTV董事会任职。从2016年4月至2017年3月，Goulet先生曾在Surgical Care Affiliates（纳斯达克股票代码:SCAI）的董事会任职，然后被UnitedHealth’；s Optum收购。Goulet先生在康涅狄格州哈特福德的三一学院（Trinity College）获得经济学学士学位。
- Ken Goulet has served as a director since the initial public offering. Mr. Goulet is a senior-level health care executive with over 30 years' experience in growing and leading large health plan organizations. From April 2004 until September 2015 Mr. Goulet worked at Anthem, Inc., most recently serving as the executive vice president, and president of the Anthem's Commercial and Specialty Business division - one of the largest commercial health insurance business divisions in the United States. In that role, he was responsible for Anthem's Individual and Exchange business, Local Blue business, National Accounts and Specialty Products. His responsibilities included strategy, marketing, product management, medical management, provider engagement and contracting and service operations. Prior to his appointment as executive vice president, Mr. Goulet served in various executive leadership roles at Anthem, including President and CEO of the Employer, Medicaid, Individual and Specialty Business Unit; President and CEO of the former Commercial Business Unit and President and CEO of National Accounts. Before joining Anthem, Mr. Goulet spent 23 years at Cigna Corporation where he held a number of management, sales and operations positions. Mr. Goulet currently serves on the board of directors of several privately held companies within the healthcare industry including Behavioral Health Group, EmpiRx, IPG, OODA Health, Quartet Health and Sharecare. He also sits on the advisory boards of Brave Health, Carecentrix and NationsHearing. From December 2015 until August 2018 Mr. Goulet served on the Board of Cotiviti NYSE: COTV, prior to its acquisition by Veritas Capital. From April 2016 until March 2017 Mr. Goulet served on the board of Surgical Care Affiliates (Nasdaq: SCAI), prior to its acquisition by UnitedHealth's Optum. Mr. Goulet received a bachelor's degree in Economics at Trinity College in Hartford, Connecticut.
高管简历
中英对照 | 中文 | 英文- James T. Olsen
JamesT.Olsen自成立以来一直担任我们的首席执行官和董事。Olsen先生是Concord的创始人兼管理合伙人，也是Concord&8217；s投资委员会的成员。Olsen先生在梦百合投资银行和投资咨询服务方面有超过24年的经验。在2017年成立Concord之前，Olsen先生曾于2013年至2016年担任多元化金融服务公司Jefferies的董事总经理兼非营利梦百合投资银行业务主管。任职Jefferies公司之前，奥尔森曾担任美银美林（Bank of America Merrill Lynch）的董事总经理兼非营利性梦百合并购主管。他的职业生涯始于1996年任职Merrill Lynch公司，在那里他曾任职17年。他目前任职于VitalTech Holdings公司（梦百合信息技术领域的协和投资组合公司，专注于远程患者监测）和Proton Therapy Partners公司（专业服务供应商，与医院公司组建合资企业，提供先进的质子治疗放射肿瘤服务）的董事会。Olsen先生在马里兰洛约拉大学（Loyola University Maryland）获得物理学学士学位，并在马里兰大学医学院（University of Maryland Graduate Program）获得生理学硕士学位。
James T. Olsen has served as our Chief Executive Officer and a Director since inception. Mr. Olsen is the Founder & Managing Partner of Concord and a member of Concord's Investment Committee. Mr. Olsen has over 24 years of experience in healthcare investment banking and investment advisory services. Prior to founding Concord in 2017 Mr. Olsen was Managing Director & Head of Not-for-Profit Healthcare Investment Banking at Jefferies, a diversified financial services company from 2013 to 2016. Prior to Jefferies, Mr. Olsen served as Managing Director & Head of Not-for-Profit Healthcare Mergers & Acquisitions at Bank of America Merrill Lynch. Mr. Olsen began his career in 1996 at Merrill Lynch where he remained for 17 years. He currently serves on the Board of Directors for VitalTech Holdings, a Concord portfolio company in the healthcare information technology sector that focuses on remote patient monitoring, and Proton Therapy Partners, a specialty service provider that forms joint ventures with hospital companies to deliver advanced proton therapy radiation oncology services. Mr. Olsen received a B.S. in Physics from Loyola University Maryland and a M.S. in Physiology from the University of Maryland Graduate Program at the School of Medicine.- JamesT.Olsen自成立以来一直担任我们的首席执行官和董事。Olsen先生是Concord的创始人兼管理合伙人，也是Concord&8217；s投资委员会的成员。Olsen先生在梦百合投资银行和投资咨询服务方面有超过24年的经验。在2017年成立Concord之前，Olsen先生曾于2013年至2016年担任多元化金融服务公司Jefferies的董事总经理兼非营利梦百合投资银行业务主管。任职Jefferies公司之前，奥尔森曾担任美银美林（Bank of America Merrill Lynch）的董事总经理兼非营利性梦百合并购主管。他的职业生涯始于1996年任职Merrill Lynch公司，在那里他曾任职17年。他目前任职于VitalTech Holdings公司（梦百合信息技术领域的协和投资组合公司，专注于远程患者监测）和Proton Therapy Partners公司（专业服务供应商，与医院公司组建合资企业，提供先进的质子治疗放射肿瘤服务）的董事会。Olsen先生在马里兰洛约拉大学（Loyola University Maryland）获得物理学学士学位，并在马里兰大学医学院（University of Maryland Graduate Program）获得生理学硕士学位。
- James T. Olsen has served as our Chief Executive Officer and a Director since inception. Mr. Olsen is the Founder & Managing Partner of Concord and a member of Concord's Investment Committee. Mr. Olsen has over 24 years of experience in healthcare investment banking and investment advisory services. Prior to founding Concord in 2017 Mr. Olsen was Managing Director & Head of Not-for-Profit Healthcare Investment Banking at Jefferies, a diversified financial services company from 2013 to 2016. Prior to Jefferies, Mr. Olsen served as Managing Director & Head of Not-for-Profit Healthcare Mergers & Acquisitions at Bank of America Merrill Lynch. Mr. Olsen began his career in 1996 at Merrill Lynch where he remained for 17 years. He currently serves on the Board of Directors for VitalTech Holdings, a Concord portfolio company in the healthcare information technology sector that focuses on remote patient monitoring, and Proton Therapy Partners, a specialty service provider that forms joint ventures with hospital companies to deliver advanced proton therapy radiation oncology services. Mr. Olsen received a B.S. in Physics from Loyola University Maryland and a M.S. in Physiology from the University of Maryland Graduate Program at the School of Medicine.
- Benson Jose
Benson Jose自成立以来一直是我们的首席财务官。Jose先生是Concord的合伙人和首席运营官/首席财务官。Jose先生在税务，会计，合规，投资者关系以及基金和公司运营方面拥有超过20年的经验。在2018年加入Concord之前，Jose先生曾担任城堡山资产管理公司（Castle Hill Asset Management）的合伙人/首席运营官/首席财务官，负责管理所有中后台运营，人力资源，基金和公司的法律和监管事务，并参与董事会。他是评估委员会的成员，负责公司的评估政策，并确保适当的指导和协议得到遵守。Jose先生负责保持公司的时效性，并符合SEC和FCA的标准。在2013年加入Castle Hill Asset Management之前，Jose先生担任MDR Capital的首席财务官/首席执行官，负责基金和管理公司的会计，合规，投资者关系和运营。作为合规委员会成员，他负责保持公司的时效性和符合SEC标准。在2011年加入MDR Capital之前，Jose先生是Greenlight Capital Management的代理财务总监。Jose从2009年到2011年在Greenlight Capital Management任职期间担任Ryan Associates（一家Advent Geneva合伙人）会计经理。Jose先生曾担任Plainfield Asset Management的会计运营总监，并管理多个基金结构的年度审计以及监管SEC备案。2006年加入Plainfield Asset Management之前，Jose在Ernst&Young Assurance&Advisory Business Services Audit Group任职，专注于私募股权、全球对冲基金和基金基金，并在金融服务办公室担任多个职位，包括合规、培训和人力资源方面的作用。Jose先生拥有圣约翰大学（St.John&8217；s University）的会计学学士学位，圣母大学（University of Notre Dame）的会计学硕士学位和圣约翰大学（St.John&8217；s University）的金融学工商管理硕士学位。
Benson Jose has served as our Chief Financial Officer since inception. Mr. Jose is a Partner and the Chief Operating Officer / Chief Financial Officer of Concord. Mr. Jose has over 20 years of experience in tax, accounting, compliance, investor relations and both fund and company operations. Prior to joining Concord in 2018 Mr. Jose was a Partner/COO/CFO at Castle Hill Asset Management with responsibility for managing all middle and back office operations, human resources, fund and firm legal and regulatory matters, as well as engagement with the Board of Directors. He was a member of the Valuation Committee responsible for the firm's valuation policy as well as ensuring proper guidance and protocols were followed. Mr. Jose was responsible for keeping the firm current and in line with both SEC and FCA standards. Prior to joining Castle Hill Asset Management in 2013 Mr. Jose served as CFO/CCO at MDR Capital, with responsibility for both fund and management company accounting, compliance, investor relations and operations. As a Compliance Committee member, he was responsible for keeping the firm current and in line with SEC standards. Prior to joining MDR Capital in 2011 Mr. Jose was the Acting Controller at Greenlight Capital Management. During his term at Greenlight Capital Management from 2009 to 2011 Mr. Jose was the Accounting Manager at Ryan Associates, an Advent Geneva partner. Mr. Jose served as the Director of Accounting Operations at Plainfield Asset Management and managed annual audits for multiple fund structures as well as regulatory SEC filings. Prior to joining Plainfield Asset Management in 2006 Mr. Jose worked at Ernst & Young within the Assurance & Advisory Business Services Audit Group with a focus on private equity, global hedge funds and fund of funds and worked in a variety of positions within the Financial Services Office, including roles in compliance, training and human resources. Mr. Jose holds a B.S. in Accountancy from St. John's University, a M.S. in Accountancy from University of Notre Dame and an M.B.A. in Finance from St. John's University.- Benson Jose自成立以来一直是我们的首席财务官。Jose先生是Concord的合伙人和首席运营官/首席财务官。Jose先生在税务，会计，合规，投资者关系以及基金和公司运营方面拥有超过20年的经验。在2018年加入Concord之前，Jose先生曾担任城堡山资产管理公司（Castle Hill Asset Management）的合伙人/首席运营官/首席财务官，负责管理所有中后台运营，人力资源，基金和公司的法律和监管事务，并参与董事会。他是评估委员会的成员，负责公司的评估政策，并确保适当的指导和协议得到遵守。Jose先生负责保持公司的时效性，并符合SEC和FCA的标准。在2013年加入Castle Hill Asset Management之前，Jose先生担任MDR Capital的首席财务官/首席执行官，负责基金和管理公司的会计，合规，投资者关系和运营。作为合规委员会成员，他负责保持公司的时效性和符合SEC标准。在2011年加入MDR Capital之前，Jose先生是Greenlight Capital Management的代理财务总监。Jose从2009年到2011年在Greenlight Capital Management任职期间担任Ryan Associates（一家Advent Geneva合伙人）会计经理。Jose先生曾担任Plainfield Asset Management的会计运营总监，并管理多个基金结构的年度审计以及监管SEC备案。2006年加入Plainfield Asset Management之前，Jose在Ernst&Young Assurance&Advisory Business Services Audit Group任职，专注于私募股权、全球对冲基金和基金基金，并在金融服务办公室担任多个职位，包括合规、培训和人力资源方面的作用。Jose先生拥有圣约翰大学（St.John&8217；s University）的会计学学士学位，圣母大学（University of Notre Dame）的会计学硕士学位和圣约翰大学（St.John&8217；s University）的金融学工商管理硕士学位。
- Benson Jose has served as our Chief Financial Officer since inception. Mr. Jose is a Partner and the Chief Operating Officer / Chief Financial Officer of Concord. Mr. Jose has over 20 years of experience in tax, accounting, compliance, investor relations and both fund and company operations. Prior to joining Concord in 2018 Mr. Jose was a Partner/COO/CFO at Castle Hill Asset Management with responsibility for managing all middle and back office operations, human resources, fund and firm legal and regulatory matters, as well as engagement with the Board of Directors. He was a member of the Valuation Committee responsible for the firm's valuation policy as well as ensuring proper guidance and protocols were followed. Mr. Jose was responsible for keeping the firm current and in line with both SEC and FCA standards. Prior to joining Castle Hill Asset Management in 2013 Mr. Jose served as CFO/CCO at MDR Capital, with responsibility for both fund and management company accounting, compliance, investor relations and operations. As a Compliance Committee member, he was responsible for keeping the firm current and in line with SEC standards. Prior to joining MDR Capital in 2011 Mr. Jose was the Acting Controller at Greenlight Capital Management. During his term at Greenlight Capital Management from 2009 to 2011 Mr. Jose was the Accounting Manager at Ryan Associates, an Advent Geneva partner. Mr. Jose served as the Director of Accounting Operations at Plainfield Asset Management and managed annual audits for multiple fund structures as well as regulatory SEC filings. Prior to joining Plainfield Asset Management in 2006 Mr. Jose worked at Ernst & Young within the Assurance & Advisory Business Services Audit Group with a focus on private equity, global hedge funds and fund of funds and worked in a variety of positions within the Financial Services Office, including roles in compliance, training and human resources. Mr. Jose holds a B.S. in Accountancy from St. John's University, a M.S. in Accountancy from University of Notre Dame and an M.B.A. in Finance from St. John's University.